BioSpace News Archive

Press Releases

Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms NDA Submission Guidance for Anaphylm™ (epinephrine) Sublingual Film

December 2, 2024
·
9 min read
Press Releases

Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS

December 2, 2024
·
5 min read
Press Releases

Rallybio to Initiate RLYB116 Confirmatory Clinical PK/PD Study in Second Quarter 2025

December 2, 2024
·
7 min read
Press Releases

Daiichi Sankyo Highlights Progress Across Oncology Portfolio in Multiple Solid and Blood Cancers at ESMO Asia, SABCS and ASH

December 2, 2024
·
16 min read
Press Releases

Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance

December 2, 2024
·
4 min read
Press Releases

Stoke Therapeutics Announces Plans to Present New Data that Support Zorevunersen as Potentially the First Disease-Modifying Medicine for Dravet Syndrome at the American Epilepsy Society 2024 Annual Meeting

December 2, 2024
·
9 min read
Press Releases

Sudo Biosciences Announces First Participants Dosed in Phase 1 Trial of Brain-Penetrant Allosteric TYK2 Inhibitor SUDO-550

December 2, 2024
·
2 min read
Press Releases

VPL Welcomes Mark Longley as Chief Executive Officer; Eric McGlade, CEO and Co-Founder, Named Chairman of the Board

December 2, 2024
·
2 min read
Press Releases

Enveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series Compounds

December 2, 2024
·
6 min read
Press Releases

Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal Cancer

December 2, 2024
·
3 min read